Chinese herba preparation for treating myocardial infarction

Abstract

The invention discloses a Chinese herba preparation for treating myocardial infarction. The Chinese herba preparation comprises, by weight, the raw material medicine of 20 g-30 g of Mangnolia officinalis, 10 g-20 g of betel nuts, 10 g-20 g of semen raphani, 10 g-20 g of akebiaquinata, 10 g-20 g of pericarpium arecae, 10 g-20 g of Angelica sinensis, 10 g-20 g of Platycodon grandiflorum, 8 g-15 g of Pinellia ternate, 8 g-12 g of cassia twigs, 8 g-12 g of pseudo-ginseng, 8 g-12 g of safflower carthamus, 8 g-12 g of Rhizoma Arisaematis Cum bile and 8 g-12 g of pollen typhae. The medicine are in good compatibility, the effects of qi benefiting, blood producing, stagnation eliminating, collaterals dredging, dampness eliminating, phlegm eliminating, blood circulating activating and stasis removing, the preparation is used for treating myocardial infarction, treating pointing to symptoms can be achieved, healthy energy is strengthened, evil eliminating is achieved, both the principal and secondary aspect of the disease are treated, compared with a traditional treating method, the preparation has the advantages of being definite in treating effect, high in safety and high in recovery rate, relapse cannot happen easily, and the preparation is worth clinic promoting and using.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine preparation capable of treating myocardial infarction. Background technique [0002] Myocardial infarction, also known as myocardial infarction, refers to myocardial necrosis caused by acute and persistent ischemia and hypoxia (coronary insufficiency). Clinically, there are severe and persistent retrosternal pain, which cannot be completely relieved by rest and nitrates, accompanied by increased white blood cells, fever, accelerated erythrocyte sedimentation rate, increased serum myocardial enzyme activity, and progressive ECG changes, which may be complicated by arrhythmia, shock, or heart failure. Complications such as failure can often be life-threatening. The disease is most common in Europe and the United States, and about 1.5 million people in the United States suffer from myocardial infarction every year. China is a low-incidenc...

AI Technical Summary

Problems solved by technology

[0004] The invention solves the current defects in the treatment of myocardial infarction, and provides a traditional Chinese medicine preparation with good curative effect, low price, no side effects, high cure rate and no relapse

Images